COVID-19 ‘Vaccine’ Deaths Soar in Europe. Mass Funeral

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
264
COVID-19 ‘Vaccine’ Deaths Soar in Europe. Mass Funeral Protest for Children Held in Switzerland
February 15, 2022

f882337961f9d533f4a0375886557eb3.png

The European database of suspected drug reactions, EudraVigilance, is now reporting 38,983 fatalities, and 3,530,362 injuries following injections of four experimental COVID-19 shots including Moderna, Pfizer, AstraZeneca and Janssen (Johnson & Johnson). Almost half of the recorded injuries are serious. On January 29, 2021 a mass funeral protest for children who have died after receiving a Pfizer vaccine was held in Geneva, Switzerland.

The European (EEA and non-EEA countries) database of suspected drug reaction reports is EudraVigilance, verified by the European Medicines Agency (EMA), and they are now reporting 38,983 fatalities, and 3,530,362 injuries following injections of four experimental COVID-19 shots:

COVID-19 MRNA VACCINE MODERNA (CX-024414)
COVID-19 MRNA VACCINE PFIZER-BIONTECH
COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
COVID-19 VACCINE JANSSEN (AD26.COV2.S)

From the total of injuries recorded, almost half of them (1,672,872 ) are serious injuries.

“Seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical occurrence that results in death, is life-threatening, requires inpatient hospitalisation, results in another medically important condition, or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, or is a congenital anomaly/birth defect.”

A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. It is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.

Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.*

Here is the summary data through January 29, 2022.

Total reactions for the mRNA vaccine Tozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer: 17,578 deaths and 1,704,757 injuries to 29/01/2022

48,240 Blood and lymphatic system disorders incl. 242 deaths
57,541 Cardiac disorders incl. 2,554 deaths
522 Congenital, familial and genetic disorders incl. 51 deaths
22,590 Ear and labyrinth disorders incl. 11 deaths
1,911 Endocrine disorders incl. 6 deaths
25,814 Eye disorders incl. 38 deaths
133,365 Gastrointestinal disorders incl. 681 deaths
422,360 General disorders and administration site conditions incl. 5,024 deaths
1,931 Hepatobiliary disorders incl. 90 deaths
18,455 Immune system disorders incl. 95 deaths
76,443 Infections and infestations incl. 1,878 deaths
33,972 Injury, poisoning and procedural complications incl. 331 deaths
42,585 Investigations incl. 502 deaths
11,344 Metabolism and nutrition disorders incl. 273 deaths
201,643 Musculoskeletal and connective tissue disorders incl. 212 deaths
1,629 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 153 deaths
278,744 Nervous system disorders incl. 1,859 deaths
2,513 Pregnancy, puerperium and perinatal conditions incl. 74 deaths
251 Product issues incl. 3 deaths
30,622 Psychiatric disorders incl. 207 deaths
6,150 Renal and urinary disorders incl. 266 deaths
68,129 Reproductive system and breast disorders incl. 6 deaths
72,531 Respiratory, thoracic and mediastinal disorders incl. 1,884 deaths
78,059 Skin and subcutaneous tissue disorders incl. 146 deaths
3,871 Social circumstances incl. 22 deaths
21,010 Surgical and medical procedures incl. 204 deaths
42,532 Vascular disorders incl. 766 deaths
Total reactions for the mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 11,008 deaths and 543,543 injuries to 29/01/2022

12,365 Blood and lymphatic system disorders incl. 120 deaths
18,287 Cardiac disorders incl. 1,142 deaths
190 Congenital, familial and genetic disorders incl. 11 deaths
6,310 Ear and labyrinth disorders incl. 8 deaths
502 Endocrine disorders incl. 6 deaths
7,475 Eye disorders incl. 36 deaths
44,340 Gastrointestinal disorders incl. 413 deaths
145,153 General disorders and administration site conditions incl. 3,630 deaths
793 Hepatobiliary disorders incl. 54 deaths
5,370 Immune system disorders incl. 22 deaths
23,070 Infections and infestations incl. 1042 deaths
10,286 Injury, poisoning and procedural complications incl. 208 deaths
12,129 Investigations incl. 393 deaths
4,847 Metabolism and nutrition disorders incl. 263 deaths
66,358 Musculoskeletal and connective tissue disorders incl. 223 deaths
682 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 85 deaths
91,230 Nervous system disorders incl. 1,029 deaths
907 Pregnancy, puerperium and perinatal conditions incl. 10 deaths
98 Product issues incl. 4 deaths
9,441 Psychiatric disorders incl. 181 deaths
3,030 Renal and urinary disorders incl. 214 deaths
12,547 Reproductive system and breast disorders incl. 9 deaths
23,251 Respiratory, thoracic and mediastinal disorders incl. 1,162 deaths
27,540 Skin and subcutaneous tissue disorders incl. 96 deaths
2,239 Social circumstances incl. 45 deaths
3,028 Surgical and medical procedures incl. 203 deaths
12,075 Vascular disorders incl. 399 deaths
Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 7,977 deaths and 1,154,757 injuries to 29/01/2022

13,912 Blood and lymphatic system disorders incl. 278 deaths
20,984 Cardiac disorders incl. 830 deaths
235 Congenital familial and genetic disorders incl. 8 deaths
13,406 Ear and labyrinth disorders incl. 7 deaths
692 Endocrine disorders incl. 6 deaths
20,086 Eye disorders incl. 32 deaths
107,453 Gastrointestinal disorders incl. 434 deaths
304,993 General disorders and administration site conditions incl. 1,855 deaths
1,039 Hepatobiliary disorders incl. 69 deaths
5,409 Immune system disorders incl. 40 deaths
42,266 Infections and infestations incl. 620 deaths
13,630 Injury poisoning and procedural complications incl. 198 deaths
25,681 Investigations incl. 205 deaths
13,023 Metabolism and nutrition disorders incl. 126 deaths
168,174 Musculoskeletal and connective tissue disorders incl. 165 deaths
743 Neoplasms benign malignant and unspecified (incl cysts and polyps) incl. 40 deaths
234,117 Nervous system disorders incl. 1,178 deaths
635 Pregnancy puerperium and perinatal conditions incl. 20 deaths
199 Product issues incl. 1 death
21,051 Psychiatric disorders incl. 69 deaths
4,338 Renal and urinary disorders incl. 78 deaths
16,849 Reproductive system and breast disorders incl. 3 deaths
41,401 Respiratory thoracic and mediastinal disorders incl. 1,082 deaths
52,064 Skin and subcutaneous tissue disorders incl. 65 deaths
1,617 Social circumstances incl. 9 deaths
1,973 Surgical and medical procedures incl. 30 deaths
28,787 Vascular disorders incl. 529 deaths
Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 2,420 deaths and 127,305 injuries to 29/01/2022

1,229 Blood and lymphatic system disorders incl. 51 deaths
2,552 Cardiac disorders incl. 204 deaths
40 Congenital, familial and genetic disorders incl. 1 death
1,319 Ear and labyrinth disorders incl. 3 deaths
105 Endocrine disorders incl. 1 death
1,656 Eye disorders incl. 10 deaths
9,588 Gastrointestinal disorders incl. 88 deaths
34,487 General disorders and administration site conditions incl. 685 deaths
153 Hepatobiliary disorders incl. 13 deaths
544 Immune system disorders incl. 10 deaths
8,521 Infections and infestations incl. 207 deaths
1,147 Injury, poisoning and procedural complications incl. 25 deaths
6,086 Investigations incl. 131 deaths
756 Metabolism and nutrition disorders incl. 60 deaths
17,116 Musculoskeletal and connective tissue disorders incl. 55 deaths
86 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 8 deaths
23,413 Nervous system disorders incl. 245 deaths
55 Pregnancy, puerperium and perinatal conditions incl. 1 death
30 Product issues
1,766 Psychiatric disorders incl. 22 deaths
535 Renal and urinary disorders incl. 31 deaths
2,941 Reproductive system and breast disorders incl. 6 deaths
4,468 Respiratory, thoracic and mediastinal disorders incl. 304 deaths
3,760 Skin and subcutaneous tissue disorders incl. 10 deaths
409 Social circumstances incl. 4 deaths
867 Surgical and medical procedures incl. 74 deaths
3,676 Vascular disorders incl. 171 deaths

https://healthimpactnews.com/2022/38983-death...itzerland/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gate's Strong Q3: Sales Growth & Rising Margins

Updated Category News Views 39

Solid Performance Boosts Confidence Gates Industrial came out swinging with their third-quarter results for 2026, showing some financial prowess that would make even the skeptics raise an eyebrow. Net sales climbed to a hefty $903.6 million, advancing 5.6% from the same time last year. It's not just smoke—core sales jumped 5.5%, signaling they're doing a bit more than...

Continue Reading
Florida's Natural, Johnsonville Settle Bet Over Juice

Updated Category News Views 154

No Such Thing as a Safe Bet When Milwaukee's Brewers edge out Tampa, it's not just about the wins and losses—it's about pride and a truckload of Florida's Natural orange juice cruising into Wisconsin. Who knew baseball could drive trades not just between players, but entire industries? In this friendly wager, the stakes were both flavorful and steep, paying homage to...

Continue Reading
Viatris Bids for Pacira: Strategic Healthcare Move

Updated Category News Views 23

Viatris Takes Strategic Step With Pacira Acquisition You ever notice how in the pharmaceutical games, it's not always the pills but the strategic moves that make the money? Viatris Inc., the global healthcare heavyweight, has just rolled the dice. They've initiated a tender offer to acquire Pacira BioSciences, a player in the non-opioid pain management market. Here's the...

Continue Reading
Z Squared Eyes 150 MW Expansion at Arkansas Site

Updated Category News Views 37

Turning Power into Potential at Union County Next stop, Union County, Arkansas. Z Squared Inc. (Nasdaq: ZSQR) isn't just talking shop; they're getting down to work. With a freshly acquired site through Paradox Data, LLC, Z Squared's planning to turn vision into reality. The site's already armed with 8 MW of juice, all ready to roll, but their ambitions shoot up to 150 MW...

Continue Reading
HIMS Faces Class Action Over Alleged Privacy Violations

Updated Category News Views 15

Got a thing for drama in the world of stocks? Well, listen up. Hims & Hers Health, Inc., the darling of digital health on the NYSE, is up to its eyeballs in a fresh securities fraud class action lawsuit over some seriously questionable practices. If you got skin in this game with HIMS between August 4, 2025, and July 29, 2026, you've got a deadline staring you down:...

Continue Reading
Tetragon's September Factsheet Offers Unique Insights

Updated Category News Views 81

A Peek into Tetragon's Financial Playbook Every once in a while, you come across a player in the finance world that operates by its own rules. Tetragon Financial Group is one of those mavericks, and they've dropped their September 2026 Monthly Factsheet. Now here's a company that knows how to keep you guessing while serving up some real financial meat. Investment Strategy...

Continue Reading
ANTHBOT N8 Wins Honors: A New Era in Lawn Care?

Updated Category News Views 67

Rising Above the Grass Well, here's a twist: ANTHBOT's latest robot mower, the N8, caught the eyes of TIME magazine and snagged a spot on their Best Inventions of 2026 list. A lawnmower? You bet. And not just any lawnmower—this one's doing a whole song and dance with its 4-in-1 approach that'll make any garden-owning homeowner's life simpler. Kudos to them for shaking...

Continue Reading
Willis Automotive Changes Hands: A Deep Dive

Updated Category News Views 117

A Historic Shift in Iowa's Auto Dealership Landscape Shifts in ownership can be like the changing of the guard, and we've got a significant one unfolding in Iowa. Rich Willis, a stalwart of the dealership game, is passing the baton—not to just anyone, but to a duo with serious heritage in the industry: Jason Willis and Collin Sewell. The transaction sees Willis...

Continue Reading
Winter Travel Booms: Top Destinations Unveiled for 2026

Updated Category News Views 75

Winter Travel Surge: Rising Demand for Top Destinations Every year as the temperature drops, the excitement for winter travel heats up, and this season's no different. Booking patterns confirm that while people are dreaming of holiday magic, they're also gunning for sun when cold's on the horizon. New York City's holiday glitz leads the domestic charge, backed by a power...

Continue Reading
Circus Circus Vegas Offers Halloween Deals for Families

Updated Category News Views 103

Halloween at Circus Circus: A New Spin on Family Fun Ah, Circus Circus Las Vegas. It's that place that’s managed to blend screaming kids, excited parents, and a flurry of flashing lights into something resembling an amusement park—on the Strip no less. Now, they're turning up the heat for Halloween. Yup, they're rolling out half-price Midway games and Adventuredome...

Continue Reading

Top 5 Most Recently Viewed Articles

Lummus and KMG Forge Digital Partnership for Industry Advancement

Updated Category News Views 159

Advancing Industrial Operations Through Digital Innovation In a significant step towards enhancing industrial operations, Lummus Technology has joined forces with KazMunayGas (KMG) to establish a digital center of excellence. This collaboration aims to propel digitalization and innovation within the petrochemical sector, ensuring that both companies are well-aligned to...

Continue Reading
Unveiling the 2026 Jeep Cherokee: A New Chapter Begins

Updated Category News Views 157

Jeep Brand Launches the All-New 2026 Jeep Cherokee The excitement around the Jeep® brand reached new heights as enthusiasts gathered for the reveal of the all-new 2026 Jeep Cherokee. This iconic SUV, a symbol of adventure and freedom, made its debut, capturing the essence of what it means to be a Jeep owner. Celebrating Heritage with LL COOL J At the heart of the event...

Continue Reading
Insights on Whale Alerts in the Financials Sector Today

Updated Category News Views 194

Understanding Whale Alerts Whale alerts serve as a crucial tool for traders aiming to identify significant trading opportunities in the financial markets. These alerts track the activities of large entities—referred to as 'whales'—that engage in high-volume trades. Observing these transactions can provide insights into market dynamics and potential price movements....

Continue Reading
Texas Capital Bancshares Declares Attractive Preferred Dividend

Updated Category News Views 53

Texas Capital Bancshares Announces Quarterly Dividend Dallas-based Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent organization of Texas Capital Bank, has recently declared an exciting cash dividend. This dividend amounts to $14.375 per share for its 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B. For investors, this translates to $0.359375...

Continue Reading
Ida Simonsen Takes the Helm as New CEO of SMCP North America

Updated Category News Views 284

Ida Simonsen Takes the Helm as New CEO of SMCP North America SMCP Group is excited to announce that Ida Simonsen has been appointed as the new President and CEO for its North American operations. Simonsen steps into this pivotal role following the departure of Paul Griffin, who has chosen to pursue new opportunities outside of the company. Ida Simonsen's Inspiring Vision...

Continue Reading